Market position Mid-sized CRO with a broad service mix (End to End, FSP, BPO, expert consulting) offering scalable clinical trial design and execution, presenting opportunities to upsell integrated services to sponsors seeking flexible resourcing and end to end delivery.

Strategic partnerships Recent and ongoing collaborations with Medidata and Dassault Systèmes signal openness to accelerators and platform-based solutions; leverage these partnerships to position joint offerings or preferred vendor programs to sponsors.

Targetable events Active participation in major life sciences events (SNMMI, BIO International, World Orphan Drug Congress) creates scheduling windows for face to face engagements with decision makers in nuclear medicine, biotechnology, and orphan drug programs.

Emerging sectors Strength in orphan drugs and rare diseases highlighted by event participation; pursue opportunities to expand services in rare/regulated indications, with a focus on regulatory strategy, patient recruitment, and data management.

Global scalability With 501-1000 employees and a global R&D services footprint, target sponsors seeking scalable CRO resources, rapid study startup, and flexible FSP/BPO models to manage growing late phase or complex trials while controlling timelines and costs.